» Articles » PMID: 35004967

Surgical Treatment of Colorectal Cancer Liver Metastases: Individualized Comprehensive Treatment Makes a Difference

Overview
Date 2022 Jan 10
PMID 35004967
Authors
Affiliations
Soon will be listed here.
Citing Articles

Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice.

Zhou X, Yang M, Yu J, Tan J, Xu N, Zhou Y J Gastrointest Oncol. 2024; 15(1):312-329.

PMID: 38482238 PMC: 10932675. DOI: 10.21037/jgo-24-25.


Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases.

Sun H, Sun L, Ke X, Liu L, Li C, Jin B Adv Sci (Weinh). 2023; 11(2):e2304460.

PMID: 37973557 PMC: 10787059. DOI: 10.1002/advs.202304460.

References
1.
Lillemoe H, Vauthey J . Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. Hepatobiliary Surg Nutr. 2020; 9(1):25-34. PMC: 7026786. DOI: 10.21037/hbsn.2019.05.14. View

2.
Hellman S, Weichselbaum R . Oligometastases. J Clin Oncol. 1995; 13(1):8-10. DOI: 10.1200/JCO.1995.13.1.8. View

3.
Abdalla E, Vauthey J, Ellis L, Ellis V, Pollock R, Broglio K . Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004; 239(6):818-25. PMC: 1356290. DOI: 10.1097/01.sla.0000128305.90650.71. View

4.
Luo Z, Chen X, Zhang Y, Huang Z, Zhao H, Zhao J . Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy. Front Cell Dev Biol. 2021; 8:577125. PMC: 7876250. DOI: 10.3389/fcell.2020.577125. View

5.
Rees M, Tekkis P, Welsh F, ORourke T, John T . Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2007; 247(1):125-35. DOI: 10.1097/SLA.0b013e31815aa2c2. View